MacroGenics
(NASDAQ) MGNX
MacroGenics Financials at a Glance
Market Cap
$275.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$157.08M
Net Income (TTM)
-$70.36M
EPS (TTM)
-$1.11
P/E Ratio
-3.90
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Price
$4.36
Volume
40,058
Open
$4.36
Price
$4.36
Volume
40,058
Open
$4.36
Previous Close
$4.36
Daily Range
$4.16 - $4.43
52-Week Range
$1.29 - $5.08
Estimated Earnings Date
Aug 13, 2026
Dividend
$0.00
Beta (Volatility)
1.44 (Average)
Price
$4.36
Volume
40,058
Open
$4.36
Previous Close
$4.36
Daily Range
$4.16 - $4.43
52-Week Range
$1.29 - $5.08
Estimated Earnings Date
Aug 13, 2026
MGNX News
Why MacroGenics Stock Tumbled Today
MGNX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout MacroGenics
Industry
Biotechnology
Sector
Health CareEmployees
293
CEO
Eric Risser, MBA
Website
www.macrogenics.comHeadquarters
Rockville, MD 20850, US
MGNX Financials
Key Financial Metrics (TTM)
Gross Margin
69.93%
Operating Margin
-40.53%
Net Income Margin
-44.79%
Return on Equity
-147.80%
Return on Capital
-44.87%
Return on Assets
-32.29%
Earnings Yield
-25.64%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$275.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
63.56M
Volume
40.06K
Avg. Volume
1.13M
Financials (TTM)
Gross Profit
$109.85M
Operating Income
-$63.66M
EBITDA
-$50.64M
Operating Cash Flow
-$69.96M
Capital Expenditure
-$1.73M
Free Cash Flow
-$71.69M
Cash & ST Invst.
$154.23M
Total Debt
$36.51M
MacroGenics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$20.78M
+57.5%
Gross Profit
$9.56M
+58.7%
Gross Margin
46.01%
N/A
Market Cap
$275.23MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$917.43K
N/A
Employees
300
N/A
Net Income
-$36.77M
+10.4%
EBITDA
-$30.20M
+22.9%
Quarterly Fundamentals
Total Cash
$154.23M
+0.1%
Total Debt
$36.51M
-2.6%
Accounts Receivable
$10.43M
-1.1%
Inventory
$9.50M
+0.8%
Long Term Debt
$31.30M
-2.5%
Short Term Debt
$5.21M
-2.9%
Return on Assets
-32.29%
N/A
Return on Invested Capital
-52.21%
N/A
Free Cash Flow
-$36.16M
+23.8%
Operating Cash Flow
-$35.81M
+23.6%